Updated study results of pelcitoclax (APG-1252) combined with osimertinib in patients (pts) with EGFR-mutant non-small-cell lung cancer (NSCLC)
| Title | Updated study results of pelcitoclax (APG-1252) combined with osimertinib in patients (pts) with EGFR-mutant non-small-cell lung cancer (NSCLC) |
|---|---|
| Description | Updated study results of pelcitoclax (APG-1252) combined with osimertinib in patients (pts) with EGFR-mutant non-small-cell lung cancer (NSCLC) |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA019805 |
| Release Date | 2023-10-25 |
| Submitter | Li Zhang (zhangli@sysucc.org.cn) |
| Organization | Sun Yat-sen University Cancer Center |
| Submission Date | 2023-09-15 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX004932-03 | APG1252NC101 (2023ESMO submission PPT) | 1 | Other Type of Genomic Data | 2.3 MB | zip | 0 | Unavailable |